Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Lifeloc Technologies (LCTC) Asset Writedowns and Impairment (2016 - 2024)

Lifeloc Technologies has reported Asset Writedowns and Impairment over the past 9 years, most recently at $1000.0 for Q4 2024.

  • For Q4 2024, Asset Writedowns and Impairment changed N/A year-over-year to $1000.0; the TTM value through Dec 2024 reached $5175.0, changed N/A, while the annual FY2025 figure was $1500.0, 25.0% down from the prior year.
  • Asset Writedowns and Impairment for Q4 2024 was $1000.0 at Lifeloc Technologies, down from $4175.0 in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $20101.0 in Q4 2020 and troughed at -$49000.0 in Q2 2021.
  • A 3-year average of -$2832.1 and a median of $2000.0 in 2020 define the central range for Asset Writedowns and Impairment.
  • Biggest five-year swings in Asset Writedowns and Impairment: surged 368.01% in 2020 and later crashed 1733.33% in 2021.
  • Year by year, Asset Writedowns and Impairment stood at $20101.0 in 2020, then crashed by 343.77% to -$49000.0 in 2021, then skyrocketed by 102.04% to $1000.0 in 2024.
  • Business Quant data shows Asset Writedowns and Impairment for LCTC at $1000.0 in Q4 2024, $4175.0 in Q3 2024, and -$49000.0 in Q2 2021.